Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting JH Oyugi, J Byakika-Tusiime, ED Charlebois, C Kityo, R Mugerwa, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (5), 1100-1102, 2004 | 373 | 2004 |
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda JH Oyugi, J Byakika-Tusiime, K Ragland, O Laeyendecker, R Mugerwa, ... Aids 21 (8), 965-971, 2007 | 351 | 2007 |
Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy J Byakika-Tusiime, JH Oyugi, WA Tumwikirize, ET Katabira, PN Mugyenyi, ... International journal of STD & AIDS 16 (1), 38-41, 2005 | 272 | 2005 |
Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining … J Byakika-Tusiime, J Crane, JH Oyugi, K Ragland, A Kawuma, P Musoke, ... AIDS and Behavior 13, 82-91, 2009 | 197 | 2009 |
Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala N Nabukeera-Barungi, I Kalyesubula, A Kekitiinwa, J Byakika-Tusiime, ... Annals of tropical paediatrics 27 (2), 123-131, 2007 | 162 | 2007 |
Uganda’s experience in Ebola virus disease outbreak preparedness, 2018–2019 JR Aceng, AR Ario, AN Muruta, I Makumbi, M Nanyunja, I Komakech, ... Globalization and Health 16, 1-12, 2020 | 90 | 2020 |
Early mortality and functional outcome after acute stroke in Uganda: prospective study with 30 day follow-up J Nakibuuka, M Sajatovic, J Nankabirwa, C Ssendikadiwa, AJ Furlan, ... Springerplus 4, 1-10, 2015 | 81 | 2015 |
Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors R Kiguba, J Byakika-Tusiime, C Karamagi, F Ssali, P Mugyenyi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (2), 218-223, 2007 | 78 | 2007 |
Circumcision and HIV infection: assessment of causality J Byakika-Tusiime AIDS and Behavior 12, 835-841, 2008 | 69 | 2008 |
Knowledge and Perception of Stroke: A Population‐Based Survey in Uganda J Nakibuuka, M Sajatovic, E Katabira, E Ddumba, J Byakika-Tusiime, ... International Scholarly Research Notices 2014 (1), 309106, 2014 | 66 | 2014 |
Late presentation with HIV in Africa: phenotypes, risk, and risk stratification in the REALITY trial A Siika, L McCabe, M Bwakura-Dangarembizi, C Kityo, J Mallewa, ... Clinical Infectious Diseases 66 (suppl_2), S140-S146, 2018 | 41 | 2018 |
Stroke-risk factors differ between rural and urban communities: population survey in Central Uganda J Nakibuuka, M Sajatovic, J Nankabirwa, AJ Furlan, J Kayima, E Ddumba, ... Neuroepidemiology 44 (3), 156-165, 2015 | 39 | 2015 |
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open … J Mallewa, AJ Szubert, P Mugyenyi, E Chidziva, MJ Thomason, ... The lancet HIV 5 (5), e231-e240, 2018 | 30 | 2018 |
Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital M Nanteza, JB Tusiime, J Kalyango, A Kasangaki BMC Oral Health 14, 1-6, 2014 | 28 | 2014 |
Ability to purchase and secure stable therapy are significant predictors of non-adherence to antiretroviral therapy in Kampala, Uganda J Byakika-Tusiime, JH Oyugi, WA Tumwikirize, ET Katabira, PN Mugyeni, ... Tenth Conference on Retroviruses and Opportunistic Infections, Boston, USA, 2003 | 26 | 2003 |
Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in Kampala, Uganda JA Hahn, M Maier, J Byakika-Tusiime, JH Oyugi, DR Bangsberg Journal of the International Association of Physicians in AIDS Care 6 (2), 83-86, 2007 | 21 | 2007 |
Evaluation of the Ebola Virus Disease (EVD) preparedness and readiness program in Uganda: 2018 to 2019 P Nsubuga, B Masiira, C Kihembo, J Byakika-Tusiime, C Ryan, ... Pan African Medical Journal 38 (1), 2021 | 16 | 2021 |
Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults J Byakika-Tusiime, LW Chinn, JH Oyugi, C Obua, DR Bangsberg, ... PLoS One 3 (12), e3981, 2008 | 16 | 2008 |
Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional … ST Wafula, IB Mugume, B Sensasi, S Okware, A Chimbaru, M Nanyunja, ... BMJ open 12 (6), e057322, 2022 | 14 | 2022 |
Effect of a 72 hour stroke care bundle on early outcomes after acute stroke: a non randomised controlled study J Nakibuuka, M Sajatovic, J Nankabirwa, C Ssendikadiwa, N Kalema, ... PloS one 11 (5), e0154333, 2016 | 12 | 2016 |